Dr. Sharadsrikar Kotturi Appointed CSO of Neuland Laboratories

Dr. Sharadsrikar V. Kotturi has been appointed as Chief Scientific Officer (CSO) of Neuland Laboratories Limited, with effect from November 22, 2023.

Dr. Sharadsrikar V. Kotturi has over 20 years of experience in R&D across organisations such as Advinus Therapeutics Limited, GVK Biosciences Private Limited, Urikot Research, Durham, and RTI International (USA), among others. His last role was with Piramal Pharma Limited, where he was designated as Senior Vice President Operations and was responsible for the P&L of Discovery Services and Peptides Business. His area of expertise includes discovery and development, analytical R&D, conceptualisation and development of sustainable chemistries for tech transfers of agrochemicals (AI, AI intermediates), electronic chemicals (OLED monomers), flavours, pharma, scientific and operational excellence, and lean labs. He holds a PhD in chemistry from Oklahoma State University (USA) and an MSc (Tech) in Chemical Technology from UDCT, Bombay.